Avia Logo

Compare Products


Jump to:
Categories
Solutions
Description
Compatibility Level
Clients
Use cases
EHR integrations
Client types
Differentiators
Keywords
Media
Company details
Jump to:
Categories
Solutions
Description
Compatibility Level
Clients
Use cases
EHR integrations
Client types
Differentiators
Keywords
Media
Company details

Categories

Solutions

Description

Product Description:

FDA Breakthrough Software as a Medical Device (SaMD) for early detection, remote monitoring of disease progression and measurement of the impact to therapy for at risk neurodegenerative patients. Psychomotor and cognition detection, monitoring, and therapeutic measurement. 

About nQ Medical, Inc.:
nQ Medical is a digital therapeutics company addressing neurocognitive and neuromotor disorder via 24/7, passive data collection via personal devices. It is a frictionless, non-invasive, early detection, remote disease progression monitoring, and therapeutic measurement modality. nQ uses an artificial intelligence company to develop computational biomarkers that have been proven in five years of clinical trials to substantially change the way disease is managed for a wide range of neuromotor and neurocognitive disorders (Alzhemer's, Parkinson's, Multiple Sclerosis, ALS, concussion, et al. The platfomr focuses on analysis of user interaction with common electronic devices to capture functional decline related to neurodegenerative disorders. The fine control of typing and touch screen kinematics together with the frequent use of electronic devices allows for precise monitoring of small changes in neurodegeneration that frequently go unnoticed by clinicians. nQ allows for early detection of disease, 24/7, passive, at home, remote monitoring of disease progression and the measurement of impact of therapy at a fraction of the cost of current gold standards. There is no required task. Just use your device as your would normally use it. Of note, as one of the company's medical advisors, Zoltan Mari, MD, of the Cleveland Clinic, so aptly quoted: "As important as it is to fund novel compounds for treating diseases, it is also important to set the stage for maximum impact when those compounds are discovered and approved for use. It is impossible to find a cure without early detection. That's why drug candidates fail. When the FDA puts its stamp on the first disease modifying drugs, such early detection technologies will be instantly necessary." He goes on to state further: "We also need a disease progression marker. Nothing so far has managed to do very well (while being profoundly expensive). Much of our research and clinical interest is turning toward disease progression. All efforts should focus on readying and perfecting early detection tools and building effective, reliable, inexpensive ways of tracking disease and the impact of therapy over time.” nQ is that early detection, disease progression computational biomarker.
Product Description:

Rimidi’s cardiometabolic platform supports disease management of some of the most prevalent and costly chronic conditions. The platform provides access to the tools required to manage multiple disease states – Diabetes, Cardiovascular Disease/Hypertension, Heart Failure, Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH), and Obesity. The platform consolidates relevant clinical data from the EMR for each disease state with patient-generated health data from connected devices or surveys, and layers clinical decision support that can be mapped against national or practice guidelines. Our cardiometabolic snapshot allows clinicians to quickly assess patient status for each comorbid disease state -- are screenings up to date? Are key metrics well-controlled?

About Rimidi:
Rimidi is a cloud-based software platform that enables personalized management of health conditions across populations. Created by doctors, Rimidi avoids the disconnect in connected care by combining patient-generated health data with clinical data from the EHR to drive patient-specific clinical insights and actions. The net effect is a better health system with optimized clinical workflows that enable better decisions, better relationships, better outcomes and ultimately a better healthcare system. For more information, visit rimidi.com and follow us on Facebook, Twitter and LinkedIn.

Compatibility level

Select which hospital or health system you work at and see a personalized compatibility level.

Clients

Select which hospital or health system you work at and see the client list

Use Cases

Description:

Late state AD patient

•Decreased mobility

•Increased risk of infection

•Dehydration

nQ

Remote monitors detect decreased motion, change in vital signs, fever

Nurse consultation triggered

Hospice care recommended, accepted, and implemented

Benefit

Avoid emergency room visit

Avoid costly hospitalization

Improved family satisfaction


Parkinson’s Disease

•Stable on therapy for 2 years

•Sees Neurologist 2x/y

•Assigned with NeuroCare in EMR

nQ

nQ monitoring of NeuroCare detects out-of-range slowing and error rate on cell phone

Nurse consultation triggered

Nurse reviews clinical state and detects depressive

features

Nurse/MD order optimal antidepressant

Nurse follows clinical response and assesses side effects

Mood and motor speed/accuracy improve

Provider/Payor

Avoid delay in diagnosis and further deterioration

Depression detection not dependent on busy neurologist

Optimal medication choice made

Nurse and nQ monitoring for efficacy and have early alert system for side effects

High patient/family satisfaction

Pediatric use cases:

None provided

Users:

Clinicians

Patients

Caregivers

Researchers

Payors

Description:
  • A physician sees a patient with poorly controlled diabetes in the office and is prompted in the Rimidi diabetes view to enroll the patient in remote monitoring and to consider a therapy adjustment to optimize cardiovascular risk reduction. The physician creates a dynamic care plan with each encounter that posts back to their EMR. The physician reviews the patient’s home glucose readings one week after therapy adjustment to ensure adequate control.
  • A patient uses the connected glucometer provided by the practice. She can see whether she is in her target range, receive messages from her care team in response to her data, and access the diabetes educational course recommended to her on her home device. She feels more connected and in control of her diabetes.
  • A care coordinator monitors a clinic’s patients with diabetes, heart failure or hypertension remotely, addressing alerts configured for the clinic and ensuring that they are meeting clinical guidelines and helping to avoid costly admissions and readmissions. Documentation for RPM and CCM activity is done in the Rimidi app and aggregate for billing purposes.
  • A primary care physician scans a patient population in the Rimidi app and sees several patients with cardiometabolic risk factors that are at risk for Nonalcoholic Fatty Liver Disease. The physician receives guideline-based, clinical decision support to guide the patients to the appropriate level of care—whether that’s a specialist referral, bloodwork, or imaging.
  • A clinic uses Rimidi to send depression screening questionnaires before all annual physician exams for their patients with heart failure and diabetes. Patients can complete the questionnaire on any device and Rimidi posts the responses back to the EMR as well as visualizing them within the Rimidi app.


Pediatric use cases:

Rimidi has developed a view specifically for tracking gaps in care in Pediatric Obesity, a major risk factor for future development of cardiometabolic conditions.

Users:

Clinicians, care teams

EHR Integrations

Integrations:

Ancillary EMR, Patient portal, Home health, Website / public online sources

EMR Integration & Relevant Hardware:

Recommended, but not required

EMRs Supported:

Self-developed

Hardware Compatibility:

Desktop, Mobile / Tablet (web optimized), Mobile / Tablet (native app), Other

Integrations:

Ambulatory EMR, Credentialing, Other

EMR Integration & Relevant Hardware:

Recommended, but not required

EMRs Supported:

Epic, Cerner, NextGen, Athenahealth, athena

Hardware Compatibility:

Desktop, Mobile / Tablet (web optimized)

Client Types

Differentiators

Differentiators vs EHR Functionality:

nQ Medical is the only FDA cleared SaMD that helps

physicians detect and track progression of diseases of cognition and motor.


Differentiators vs Competitors:
  • No proprietary equipment
  • No task-based apps
  • Generates data every 90 secs
  • Near 100% adherence



Your own device continuously assesses your neurological health… automatically, everyday

Differentiators vs EHR Functionality:

In the sales process, we often hear “Doesn’t Epic (or other EHR) do that?” Rimidi is not built to replace the EHR, but to enhance it by bringing in additional data sets, providing more efficient workflows, and improving the user experience. Rimidi can install and configure its platform within 3-6 weeks which is significantly faster and more cost effective than onsite EHR teams can build and support enhancements to meet clinical needs. Rimidi’s modern technology stack enables rapid cycle innovation and iteration post-go live.

Differentiators vs Competitors:

Rimidi’s cardiometabolic platform is most often compared to other Remote Patient Monitoring solutions, but the platform-approach to RPM allows Rimidi to do so much more. Some key differentiators of the Rimidi platform are: (1) tight integration with leading EHRs via SMART on FHIR, (2) the breadth of the comorbid disease states we cover, (3) our incorporations of patient-reported outcomes and social determinants of health measures and (4) our Clinical Decision Support engine. Rimidi’s CDS cards support almost any insight or intervention a client wants: RPM data alerting and interventions, referral management, lab or medication recommendations, clinical trial identification, and more. 



Keywords

Images

1 of 1

edit-media
NeuroCare.jpg

1 of 3

edit-media
Comprehsnsive Cardiometabolic Snapshot.png

Videos

1 of 1

edit-media
Addressing the technology crisis in Neuropsychology

No videos provided

Downloads

No content provided

Alternatives

Company Details

Founded in 2016

Founded in 2012

Need help narrowing down products?

Add more criteria to see your compatibility level for every vendor. It only takes a few minutes, just create a free account to get started.
back to top